Invention Grant
- Patent Title: Gene therapy for diabetic neuropathy using an HGF isoform
-
Application No.: US14355792Application Date: 2012-03-27
-
Publication No.: US09963493B2Publication Date: 2018-05-08
- Inventor: Jong Mook Kim , Jae Gyun Jeong
- Applicant: Jong Mook Kim , Jae Gyun Jeong
- Applicant Address: KR Seoul
- Assignee: VIROMED CO., LTD.
- Current Assignee: VIROMED CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Fenwick & West LLP
- Priority: KR10-2011-0113786 20111103
- International Application: PCT/KR2012/002224 WO 20120327
- International Announcement: WO2013/065913 WO 20130510
- Main IPC: C07K14/475
- IPC: C07K14/475 ; A61K48/00 ; A61K38/18 ; A61K31/711
Abstract:
The present invention relates to a pharmaceutical composition for the prevention or treatment of diabetic neuropathy, wherein the pharmaceutical composition comprises, as active ingredients, different types of isoforms of HGF or a polynucleotide encoding the isoforms. The present invention is the first invention demonstrating that diabetic neuropathy can be prevented and treated using different types of isoforms of HGF. According to the present invention, it is possible to very effectively treat diabetic neuropathy.
Public/Granted literature
- US20140296142A1 GENE THERAPY FOR DIABETIC NEUROPATHY USING AN HGF ISOFORM Public/Granted day:2014-10-02
Information query
